Candel Therapeutics, Inc. CADL Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Candel Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestAndOtherIncome.
The official record: Candel Therapeutics, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Candel Therapeutics, Inc.'s interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Candel Therapeutics, Inc.'s interest income?
- Candel Therapeutics, Inc. (CADL) reported interest income of $1.32M in Q1 2026.
- How has Candel Therapeutics, Inc.'s interest income changed year-over-year?
- Candel Therapeutics, Inc.'s interest income increased by 41.5% year-over-year, from $934K to $1.32M.
- What is the long-term trend for Candel Therapeutics, Inc.'s interest income?
- Over 4 years (2021 to 2025), Candel Therapeutics, Inc.'s interest income has grown at a 194.6% compound annual growth rate (CAGR), from -$52K to $3.92M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.